Magnasense - the company
The unique platform
Magnasense Technologies platform for lateral-flow immunochromatographic tests improves sensitivity and precision compared to classical lateral-flow tests. Utilising antibodies labelled with paramagnetic particles, results in a robust, affordable, portable, easy to use flexible instrument.
Magnasense Technologies’ multifunctional open-platform is applicable to many areas of Point-of-Care testing in human, veterinary, food safety and environmental applications.
Based on solid scientifical background
Magnasense Technologies originated from the world leading nanotechnology centre at the University of Jyväskylä. The expertise of physicists, biologists and electronics engineers was combined to create a patented, novel, point-of-care lateral flow (immunochromatographic) assay system utilising paramagnetic nanoparticles as labels.
By utilising a solid-state magnetometer, the reader is simplified and the need for light sources and optics is eliminated. This makes the reader robust and eliminates many of the costs and problems associated with point-of-care testing. Utilising paramagnetic labelling means that the whole reaction volume is read, not just the surface, as in optical methods, potentially increasing the signal by a factor of ten with increased assay sensitivity and reproducibility.
Improving Quality of Life through Fast, Accurate and Affordable Point‑of‑Care Testing.
Magnasense Technologies is actively promoting its technology worldwide and has recently developed its first assay for the clinically important biomarker of infection and inflammation , C-Reactive protein (CRP) - Magnia® CRP.
If you have a need for a high performance and affordable PoC system,
please contact us. Magnasense Technologies is actively looking for development partners.
We look forward to hearing from you.